Buying $1000 In MASI: If an investor had bought $1000 of MASI stock 10 years ago, it would be worth $6,316.76 today based on ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Masimo (MASI), which belongs to the Zacks ...

Masimo has expanded the board with the addition of former Stryker President Timothy Scannell and Lane Holdings Chair Wendy ...

Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its research and development (R&D) ...

Irvine-based Masimo Corp. announced it has added Timothy Scannell and Wendy Lane to its board of directors, effective ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $165.00.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.04% of ...

Sept 25 (Reuters) - Masimo (MASI.O), opens new tab said on Wednesday founder Joe Kiani has decided to step down as the medical device maker's CEO, days after shareholders voted to remove him from ...

Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company’s Board of Directors (the "Board"), ...

Today the Board of Directors (the “Board”) of Masimo (Nasdaq: MASI) a leading global medical innovator, provided a series of leadership and business u ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Masimo (MASI) shares soared 8.7% in the last trading session to close at $121.42. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to ...